Joël de Beer, Anjarium Biosciences CSO
Pfizer backs a small Swiss upstart's attempt to discover a non-viral gene therapy
Joël de Beer made it just a few months into his PhD program at ETH Zurich before he dropped out to join the hunt for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
